Bronstein, Gewirtz & Grossman LLC Urges Ardent Health, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
GlobeNewswire Inc.
•
•By Bronstein, Gewirtz & Grossman Llc
A class action lawsuit has been filed against Ardent Health, Inc. alleging that the company made materially false and misleading statements regarding its Q3 2025 revenue and 2025 EBITDA guidance. The complaint claims revenue was overstated due to inadequate accounts receivable assessments following a new accounting system transition, and EBITDA guidance was overstated by approximately $57.5 million (9.6%) due to industry-wide cost pressures and payer denials. Investors who purchased Ardent securities between July 18, 2024 and November 12, 2025 are encouraged to join the lawsuit, with a lead plaintiff deadline of March 9, 2026.